|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$87||Benefits minus costs||($425)|
|Participants||$25||Benefit to cost ratio||$0.08|
|Others||$86||Chance the program will produce|
|Indirect||($161)||benefits greater than the costs||49 %|
|Net program cost||($462)|
|Benefits minus cost||($425)|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Clinical diagnosis of an anxiety disorder (e.g., general anxiety, panic, social anxiety, obsessive compulsive disorder) or symptoms measured on a validated scale.
Major depressive disorder
Clinical diagnosis of major depression or symptoms measured on a validated scale.
Disruptive behavior disorder symptoms
Clinical diagnosis of a disruptive behavior disorder (e.g., conduct disorder, oppositional defiant disorder) or symptoms measured on a validated scale.
Externalizing behavior symptoms
Symptoms of externalizing behavior (e.g., aggressive, hostile, or disruptive behavior) measured on a validated scale.
How well individuals (typically those who are developmentally disabled or seriously mentally ill) have adapted to activities of daily living.
Symptoms of internalizing behavior (e.g., sadness, anxiety, or withdrawal) measured on a validated scale.
Admission to a psychiatric ward or hospital.
An attempt to die by suicide resulting in survival.
Thinking about and/or planning death by suicide.
Visits to a specialist healthcare provider, such as an oncologist or an endocrinologist.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Disruptive behavior disorder symptoms||K-12 grade repetition||$1||$0||$0||$1||$2|
|Major depressive disorder||Labor market earnings associated with major depression||$0||$0||$0||$0||$0|
|Health care associated with major depression||$75||$21||$77||$37||$211|
|Mortality associated with depression||$2||$4||$0||$28||$33|
|Externalizing behavior symptoms||Criminal justice system||$0||$0||($1)||$0||($1)|
|K-12 special education||$0||$0||$0||$0||($1)|
|Health care associated with externalizing behavior symptoms||($2)||($1)||($3)||($1)||($7)|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($225)||($200)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$1,245||2015||Present value of net program costs (in 2018 dollars)||($462)|
|Comparison costs||$753||2010||Cost range (+ or -)||15 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Brent, D.A., Holder, D., Kolko, D., Birmaher, B., Baugher, M., Roth, C., . . . Johnson, B.A. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54(9), 877-885.
Clarke, G., DeBar, L.L., Pearson, J.A., Dickerson, J.F., Lynch, F.L., Gullion, C.M., & Leo, M.C. (2016). Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial. Pediatrics, 137(5), 1-13.
Clarke, G.N., Hornbrook, M., Lynch, F., Polen, M., Gale, J., O'Connor, E., . . . Debar, L. (2002). Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. Journal of the American Academy of Child & Adolescent Psychiatry, 41(3), 305-313.
Clarke, G.N., Rohde, P., Lewinsohn, P.M., Hops, H., & Seeley, J.R. (1999). Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions. Journal of the American Academy of Child & Adolescent Psychiatry, 38(3), 272-279.
Curtis, S.E. (1992). Cognitive-behavioral treatment of adolescent depression: effects on multiple parameters.
Kahn, J.S., Kehle, T.J., Jenson, W.R., & Clark, E. (1990). Comparison of cognitive-behavioral, relaxation, and self-modeling interventions for depression among middle-school students. School Psychology Review, 19(2), 196-211.
Kennard, B., Silva, S., Vitiello, B., Curry, J., Kratochvil, C., Simons, A., et al. (2006). Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). Journal of the American Academy of Child & Adolescent Psychiatry, 45(12), 1404-1411.
Lewinsohn, P.M., Clarke, G.N., Hops, H. & Andrews, J. (1990). Cognitive-behavioral treatment for depressed adolescents. Behavior Therapy, 21(4), 385-401.
Liddle, B. & Spence, S.H. (1990). Cognitive-behaviour therapy with depressed primary school children: A cautionary note. Behavioural Psychotherapy, 18(2), 85-102.
Listug-Lunde, L., Vogeltanz-Holm, N., & Collins, J. (2013). A cognitive-behavioral treatment for depression in rural American Indian middle school students. American Indian and Alaska Native Mental Health Research, 20(1), 16-34.
March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., et al. (2004). Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA, 292(7), 807-820.
Rohde, P., Clarke, G.N., Mace, D.E., Jorgensen, J.S., & Seeley, J.R. (2004). An efficacy/effectiveness study of cognitive-behavioral treatment for adolescents with comorbid major depression and conduct disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 43(6), 660-668.
Rossello, J., Bernal, G. (1999). The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. Journal of Consulting and Clinical Psychology, 67(5), 734-745.
Stark, K.D., Reynolds, W.M., & Kaslow, N.J. (1987). A comparison of the relative efficacy of self-control therapy and a behavioral problem-solving therapy for depression in children. Journal of Abnormal Child Psychology, 15(1), 91-113.
Vitiello, B., Rohde, P., Silva, S., Wells, K., Casat, C., Waslick, B., et al. (2006). Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child & Adolescent Psychiatry, 45(12), 1419-1426.
Vostanis, P., Feehan, C., Grattan, E., & Bickerton, W.L. (1996). Treatment for children and adolescents with depression: Lessons from a controlled trial. Clinical Child Psychology and Psychiatry, 1(2), 199-212.
Weisz, J.R., Southam-Gerow, M.A., Gordis, E.B., Connor-Smith, J.K., Chu, B.C., Langer, D.A., . . . Weiss, B. (2009). Cognitive-behavioral therapy versus usual clinical care for youth depression: An initial test of transportability to community clinics and clinicians. Journal of Consulting and Clinical Psychology, 77(3), 383-396.
Weisz, J.R., Thurber, C.A., Sweeney, L., Proffitt, V.D., & LeGagnoux, G.L. (1997). Brief treatment of mild-to-moderate child depression using primary and secondary control enhancement training. Journal of Consulting and Clinical Psychology, 65(4), 703-707.
Wood, A., Harrington, R., & Moore, A. (1996). Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 37(6), 737-746.